Vitamin D May Treat or Prevent Allergy to Common Mold

Research has discovered that vitamin D may be an effective therapeutic agent to treat or prevent allergy to a common mold.

Research conducted by Dr. Jay Kolls, Professor and Chair of Genetics at LSU Health Sciences Center New Orleans, and colleagues, has found that vitamin D may be an effective therapeutic agent to treat or prevent allergy to a common mold that can complicate asthma and frequently affects patients with Cystic Fibrosis. The work is scheduled to be published online August 16, 2010, ahead of the print edition of the September 2010 issue of the Journal of Clinical Investigation.

Aspergillus fumigatus, is one of the most prevalent fungal organisms inhaled by people.  In asthmatics and in patients with Cystic Fibrosis, it can cause significant allergic symptoms.

According to Physorg:
“The researchers focused on Th2 cells — the hormonal messengers of T-helper cells that produce an allergic response … The researchers discovered that heightened Th2 reactivity … correlated with a lower average blood level of vitamin D.”

Resources:
Journal of Clinical Investigation August 16, 2010
Physorg August 16, 2010

Enhanced by Zemanta

Leave a Reply

Your email address will not be published. Required fields are marked *